China’s 2nd protein subunit COVID-19 vaccine to enter clinical trial, easy to mass produce

, , Comments Off on China’s 2nd protein subunit COVID-19 vaccine to enter clinical trial, easy to mass produce

VCG. China’s COVID-19 protein subunit vaccines have reported encouraging progress as a leading Chinese vaccine producer, Sinopharm, plans to b …
( read original story …)